Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 16;9(3):1797-1798.
doi: 10.1002/ccr3.3768. eCollection 2021 Mar.

New onset of sinoatrial block in a young patient treated with systemic meglumine antimoniate

Affiliations

New onset of sinoatrial block in a young patient treated with systemic meglumine antimoniate

Najla Daadaa et al. Clin Case Rep. .

Abstract

The sinoatrial block is a new side effect of meglumine antimoniate. Prompt interruption of the drug results in the normalization of electrographic changes and prevents sudden cardiac arrest.

Keywords: cardiotoxicity; cutaneous leishmaniasis; meglumine antimoniate.

PubMed Disclaimer

Conflict of interest statement

No conflict of interest.

Figures

FIGURE 1
FIGURE 1
ECG before meglumine antimoniate: Positive T waves in V4‐V5‐V6, QTc = 410 ms, FC = 78 bpm
FIGURE 2
FIGURE 2
ECG after 10 days of meglumine antimoniate: Flattened T waves in V3‐V4‐V5‐V6, sinoauricular block type 2, QTc = 474 ms, FC = 50 bpm
FIGURE 3
FIGURE 3
ECG 4 days after interrupting meglumine antimoniate: Positive T waves in V4‐V5‐V6, QTc = 428 ms, FC = 57 bpm

References

    1. Matoussi N, Ameur HB, Amor SB, Fitouri Z, Becher SB. Toxicité cardiaque de l’antimoniate de meglumine (Glucantime) à propos d’une obsevation. Med Mal Infect. 2007;37:257‐259. - PubMed
    1. Sundar S, Probhat R, Nutan KA, et al. A cluster of cases of severe cardio toxicity among Kala –Azar patients treated with a high osmolarity lot of sodium antimony gluconate. Am Trop Med Hyg. 1998;59:139‐143. - PubMed
    1. Kuryshev YA, Wang L, Wible BA, Yuri A, Wan X, Ficker E. Antimony‐based anti leishmanial compounds prolong the cardiac action potential by an increase in cardia calcium currents. Mol Pharmacol. 2006;69:1216‐1225. - PubMed

LinkOut - more resources